Dianthus Therapeutics Inc
DNTHHealthcare|Biotechnology|USA
$97.54
-2.41 (-2.41%)
Tangible Book
$22.01
Upcoming Data Readouts (3)
Dec 2026
Est. completion
NAGestational Diabetes Mellitus
Gestational Diabetes and Perinatal Depression: an Intervention Program
NCT05800509n=600
Dec 2028
Est. completion
P3Myasthenia Gravis, Generalized
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
NCT07647510n=195
Dec 2028
Est. completion
P3Chronic Inflammatory Demyelinating Polyneuropathy
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
NCT06858579n=256
Awaiting Results (1)
Trials past primary completion date but still active — data readout may be imminent.
Jul 2025
P2
A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)
NCT06282159